Electrodeposition of CuGaSe2 and CuGaS2 thin films for photovoltaic applications

The final publication is available at Springer via http://dx.doi.org/10.1007/s10008-016-3237-0.Abstract CuGaSe2 and CuGaS2 polycrystalline thin film absorbers were prepared by one-step electrodeposition from an aqueous electrolyte containing CuCl2, GaCl3 and H2SeO3. The pH of the solution was adjusted to 2.3 by adding HCl and KOH. Annealing improved crystallinity of CuGaSe2 and further annealing in sulphur atmosphere was required to obtain CuGaS2 layers. The morphology, topography, chemical composition and crystal structure of the deposited thin films were analysed by scanning electron microscopy, atomic force microscopy, energy dispersive spectroscopy and X-ray diffraction, respectively. X-Ray diffraction showed that the asdeposited CuGaSe2 film exhibited poor crystallinity, but which improved dramatically when the layers were annealed in forming gas atmosphere for 40 min. Subsequent sulphurization of CuGaSe2 films was performed at 400 °C for 10 min in presence of molecular sulphur and under forming gas atmosphere. The effect of sulphurization was the conversion of CuGaSe2 into CuGaS2. The formation of CuGaS2 thin films was evidenced by the shift observed in the X-ray diffraction pattern and by the blue shift of the optical bandgap. The bandgap of CuGaSe2 was found to be 1.66 eV, while for CuGaS2 it raised up to 2.2 eV. A broad intermediate absorption band associated to Cr and centred at 1.63 eV was observed in Cr-doped CuGaS2 films.This work was supported by Ministerio de Economia y Competitividad (ENE2013-46624-C4-4-R) and Generalitat Valenciana (Prometeus 2014/044). One of the authors (S. Ullah) acknowledges the European Union (IDEAS-Call-3, Innovation and Design for Euro-Asian scholars) for its financial support.Ullah, S.; Mollar García, MA.; Marí, B. (2016). Electrodeposition of CuGaSe2 and CuGaS2 thin films for photovoltaic applications. Journal of Solid State Electrochemistry. 20(8):2251-2257. https://doi.org/10.1007/s10008-016-3237-0S22512257208Calixto ME, Sebastian PJ, Bhattacharya RN, Noufi (1999) Sol Energ Mat Sol C 59:75–84Mandati S, Sarada BV, Dey SR, Joshi SV (2015) J Power Sources 273:149–157Jacobsson TJ, Fjällström V, Edoff M, Edvinsson T (2015) Sol Energ Mat Sol C 134:185–193Carrete A, Placidi M, Shavel A, Pérez Rodríguez A, Cabot A (2015) Phys Stat Sol (a) 212:67–71Saji VS, Ik-Ho C, Lee CW (2011) Sol Energy 86:2666–2678Park MG, Ahn SJ, Yun JH, Gwak J, Cho A, Ahn SK, Shin K, Nam D, Cheong H, Yoon K (2012) J Alloy Compd 513:68–74Saji VS, Lee SM, Lee CW (2011) J Korean Electrochem Soc 14:61–70Donglin X, Jangzhuang L, Man X, Xiujian Z (2008) J Non-Cryst Solids 354:1447–1450Araujo J, Ortíz R, López-Rivera A, Ortega JM, Montilla M, Alarcón D (2007) J Solid State Electroch 11(Issue 3):407–412Palacios P, Sanchez K, Conesa JC, Fernandez JJ, Wahnon P (2007) Phys Stat Sol A 203:1395–1401Palacios P, Sanchez K, Conesa JC, Wahnon P (2006) Thin Solid Films 515:6280–6284Lee H, Lee J-H, Hwang Y-H, Kim Y (2014) Curr Appl Phys 14:18–22Kim D, Kwon Y, Lee D, Yoon S, Lee S, Yoo B (2015) J Electrochem Soc 162:D36–D41Hou WW, Bob B, Li S, Yang Y (2009) Thin Solid Films 517:6853–6856Lee J, Lee W, Shrestha NK, Lee DY, Lim I, Kang SH, Nah YC, Lee SH, Yi W, Han SH (2014) Mater Chem Phys 144:49–54Yang JY, Lee D, Huh K, Jung SJ, Lee JW, Lee HC, Baek DH, Kim BJ, Kim D, Nam J, Kim GY, Jo W (2015) RSC Adv 5:40719–407257Sall T, Nafidi A, Marí B, Mollar M, Hartiti B, Fahoume M (2014) J Semicond 35:0630021–0630025Lee JH, Song WC, Yi JS, Joonyang K, Han WD, Hawang J (2003) Thin Solid Films 431-432:349–353Prabukanthan P, Dhanasekaran R (2007) Cryst Growth Des 7:618–623Guillemoles JF, Cowache P, Lusson A, Fezzaa K, Boisivon F, Vedel J, Lincot D (1996) J Appl Phys 79:7293–7302Aguilera I, Palacios P, Wahon P (2010) Sol Energ Mat Sol C 94:1903–1906Palacios P, Aguilera I, Wahnón P, Conesa JC (2008) J Phys Chem C 112:9525–952

Fermentation, Isolation, Structure, and antidiabetic activity of NFAT-133 produced by Streptomyces strain PM0324667

Type-2 diabetes is mediated by defects in either insulin secretion or insulin action. In an effort to identify extracts that may stimulate glucose uptake, similar to insulin, a high throughput-screening assay for measuring glucose uptake in skeletal muscle cells was established. During the screening studies to discover novel antidiabetic compounds from microbial resources a Streptomyces strain PM0324667 (MTCC 5543, the Strain accession number at Institute of Microbial Technology, Chandigarh, India), an isolate from arid soil was identified which expressed a secondary metabolite that induced glucose uptake in L6 skeletal muscle cells. By employing bioactivity guided fractionation techniques, a tri-substituted simple aromatic compound with anti-diabetic potential was isolated. It was characterized based on MS and 2D NMR spectral data and identified as NFAT-133 which is a known immunosuppressive agent that inhibits NFAT-dependent transcription in vitro. Our investigations revealed the antidiabetic potential of NFAT-133. The compound induced glucose uptake in differentiated L6 myotubes with an EC50 of 6.3 ± 1.8 μM without activating the peroxisome proliferator-activated receptor-γ. Further, NFAT-133 was also efficacious in vivo in diabetic animals and reduced systemic glucose levels. Thus it is a potential lead compound which can be considered for development as a therapeutic for the treatment of type-2 diabetes. We have reported herewith the isolation of the producer microbe, fermentation, purification, in vitro, and in vivo antidiabetic activity of the compound

Trichostatin A enhances acetylation as well as protein stability of ERα through induction of p300 protein

This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Abstract Introduction Trichostatin A (TSA) is a well-characterized histone deacetylase (HDAC) inhibitor. TSA modifies the balance between HDAC and histone acetyltransferase activities that is important in chromatin remodeling and gene expression. Although several previous studies have demonstrated the role of TSA in regulation of estrogen receptor alpha (ERα), the precise mechanism by which TSA affects ERα activity remains unclear. Methods Transient transfection was performed using the Welfect-EX™Plus procedure. The mRNA expression was determined using RT-PCR. Protein expression and interaction were determined by western blotting and immunoprecipitation. The transfection of siRNAs was performed using the Oligofectamine™ reagent procedure. Results TSA treatment increased acetylation of ERα in a dose-dependent manner. The TSA-induced acetylation of ERα was accompanied by an increased stability of ERα protein. Interestingly, TSA also increased the acetylation and the stability of p300 protein. Overexpression of p300 induced acetylation and stability of ERα by blocking ubiquitination. Knockdown of p300 by RNA interference decreased acetylation as well as the protein level of ERα, indicating that p300 mediated the TSA-induced stabilization of ERα. Conclusions We report that TSA enhanced acetylation as well as the stability of the ERα protein by modulating stability of p300. These results may provide the molecular basis for pharmacological functions of HDAC inhibitors in the treatment of human breast cancer

Identification of Estrogen Receptor Dimer Selective Ligands Reveals Growth-Inhibitory Effects on Cells That Co-Express ERα and ERβ

Estrogens play essential roles in the progression of mammary and prostatic diseases. The transcriptional effects of estrogens are transduced by two estrogen receptors, ERα and ERβ, which elicit opposing roles in regulating proliferation: ERα is proliferative while ERβ is anti-proliferative. Exogenous expression of ERβ in ERα-positive cancer cell lines inhibits cell proliferation in response to estrogen and reduces xenografted tumor growth in vivo, suggesting that ERβ might oppose ERα's proliferative effects via formation of ERα/β heterodimers. Despite biochemical and cellular evidence of ERα/β heterodimer formation in cells co-expressing both receptors, the biological roles of the ERα/β heterodimer remain to be elucidated. Here we report the identification of two phytoestrogens that selectively activate ERα/β heterodimers at specific concentrations using a cell-based, two-step high throughput small molecule screen for ER transcriptional activity and ER dimer selectivity. Using ERα/β heterodimer-selective ligands at defined concentrations, we demonstrate that ERα/β heterodimers are growth inhibitory in breast and prostate cells which co-express the two ER isoforms. Furthermore, using Automated Quantitative Analysis (AQUA) to examine nuclear expression of ERα and ERβ in human breast tissue microarrays, we demonstrate that ERα and ERβ are co-expressed in the same cells in breast tumors. The co-expression of ERα and ERβ in the same cells supports the possibility of ERα/β heterodimer formation at physio- and pathological conditions, further suggesting that targeting ERα/β heterodimers might be a novel therapeutic approach to the treatment of cancers which co-express ERα and ERβ

Nanomaterials for corrosion control

Nanomaterials are important due to their unique properties that may lead to new and exciting applications. Current scenario of application of nanotechnology in the field of corrosion prevention of metals is reviewed here. Recent research and developments in this area are discussed in designing efficient coating materials and alloys, which provide superior resistance to corrosion

Interaction between Ni/NiONi/NiO and PbTiO3PbTiO_3: Phase Reversal with Redox Switching

In some applications it is useful to have $Pb(Zr,Ti)O_3$ (PZT) films printed and fired on metallic substrates because of low cost, ease of handling, and mechanical flexibility of the substrate. As part of the systematic studies on phase compatibility of metallic substrates with PZT ceramics, studies have been conducted on the interaction between Ni and $PbTiO_3$ under oxidizing and neutral conditions at 1123 K. Phase relations in the pseudoternary system $NiO-PbO-TiO_2$ and quaternary $Ni-Pb-NiTiO_3-PbTiO_3$ were explored by equilibrating compacted mixtures of component oxides and/or metals in air and prepurified Ar gas. The equilibrium phases were identified by x-ray diffraction and energy dispersive spectroscopy. The results suggest that NiO is phase compatible with $PbTiO_3$. When nickel surface is oxidized, NiO is in direct contact with $PbTiO_3$ and there is no displacement reaction between NiO and $PbTiO_3$. However, in neutral and reducing conditions metallic Ni reacts with $PbTiO_3$ to form $NiTiO_3$ and a lead-rich alloy, with catastrophic consequences in device applications. The results are rationalized using a thermodynamic analysis. The nature of phase relations in the system $Ni-Pb-Zr-O$ is elucidated using thermodynamic data

Nanotechnology in biomedical applications: A review

Incorporation of functionalised and modified nanostructures in various biomedical applications has generated considerable research interest in recent years. The applications of nanotechnology in medicine and biomedical engineering are vast and spans areas such as implant and tissue engineering, diagnosis and therapy. The present scenario demands designing of nanotools which can respond to the needs of biological problems and prepare more efficient biomedical approaches. This article reviews recent developments in nanobiotechnology with special emphasis on load bearing implants and novel tissue engineered scaffolds. Novel research approaches in nanomedicine an major challenges to practical applications are also highlighted. Copyright © 2010 Inderscience Enterprises Ltd.link_to_subscribed_fulltex

Thermodynamic evidence for order-disorder transition in NiTiO3NiTiO_3

The standard Gibbs free energy of formation of $NiTiO_3$ from its component oxides NiO with rock salt structure and $TiO_2$ with rutile structure $\Delta_f G^o_{(ox)} (NiTiO_3)$ has been measured over a wide temperature range (900 to 1700) K employing the solid-state electrochemical cell: $Pt|Ni+NiTiO_3+TiO_2||(Y_2O_3)ZrO_2||Ni+NiO|Pt$ The measured EMF, which is directly related to the Gibbs free energy of formation of $NiTiO_3$ from component oxides, can be represented by two linear segments; E\pm 0.38/(mV)=63.48-0.01264 (T/K), in the range T = (900 to 1565) K, and E\pm 0.35/(mV)=-16.21-0.03831 (T/K) in the range T = (1565 to 1700) K. The change in slope at T = 1565 K is related to the transition from ordered ilmenite structure of $NiTiO_3$ with space group $R\bar{3}$ to a kind of disordered corundum structure with space group, $R\bar{3}c$ involving essentially an order–disorder transition on the cationic sublattice. The new measurements help to resolve discrepancies in thermodynamic data on $NiTiO_3$ reported in the literature